Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Stock Traders Daily
Provider: Pechala's Reports
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA's Sanofi Pasteur Begins Domestic PII Study of Vaccine Against Clostridium Difficile Infections-Pharma Japan

Sunday, 14 Jul 2013 08:00pm EDT 

Pharma Japan reported that Sanofi SA announced on July 9, 2013 that its Sanofi Pasteur vaccine division has begun a domestic PII study of a vaccine against Clostridium difficile infections (CDIs), the major cause of infectious diarrhea in hospitals. The Company is aiming for the global launch of its anti-CDI vaccine. 

Company Quote

-3.12 -3.38%
29 May 2015